Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.32 USD | -0.30% | +7.93% | -3.53% |
Apr. 09 | Cantor Fitzgerald Initiates Structure Therapeutics at Overweight Rating With $65 Price Target | MT |
Mar. 21 | ADRs Edge Higher; Lufax Climbs Almost 46% | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 28.57M | Capitalization | 1.83B |
---|---|---|---|---|---|
Net income 2024 * | -127M | Net income 2025 * | -112M | EV / Sales 2024 * | - |
Net cash position 2024 * | 345M | Net cash position 2025 * | 150M | EV / Sales 2025 * | 58.9 x |
P/E ratio 2024 * |
-40.9
x | P/E ratio 2025 * |
-39.1
x | Employees | 93 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.06% |
1 day | -0.30% | ||
1 week | +7.93% | ||
Current month | -0.30% | ||
1 month | -3.86% | ||
3 months | -12.76% | ||
6 months | -46.77% | ||
Current year | -3.53% |
Managers | Title | Age | Since |
---|---|---|---|
Raymond Stevens
FOU | Founder | 60 | 19-01-31 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 19-01-31 |
Ying Li Ma
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Tetlow
BRD | Director/Board Member | 64 | 22-03-28 |
Ted Love
BRD | Director/Board Member | 65 | 23-08-02 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 22-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 39.32 | -0.30% | 631,784 |
24-04-30 | 39.44 | +1.02% | 707,077 |
24-04-29 | 39.04 | +0.26% | 183,155 |
24-04-26 | 38.94 | -0.10% | 972,594 |
24-04-25 | 38.98 | +7.00% | 396,566 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.53% | 1.83B | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.52% | 22.25B | |
-14.77% | 21.68B | |
-7.42% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- GPCR Stock